Advanced Prostate Cancer Clinical Trial
Official title:
A Two Arm, Multi Centric, Randomised, Open Label, Parallel Study to Compare Pharmacodynamics of Subcutaneous Goserelin 10.8mg Injection (Sponsor) With ZOLADEX® 10.8mg Injection (AstraZeneca) in Patients With Advanced Prostate Cancer
A two arm, multi centric, randomized, open label, parallel, two doses pharmacodynamics study in patients with advanced prostate cancer.
A phase III, two arm, multi centric, randomized, open label, parallel, two doses pharmacodynamics study in patients with advanced prostate cancer. Each patient will have 25 visits total. Total duration of the study will be 183 days (including up to 14 days of screening). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06006104 -
Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT02234089 -
Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.
|
||
Completed |
NCT01078545 -
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
|
N/A | |
Active, not recruiting |
NCT03511196 -
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
|
Early Phase 1 | |
Recruiting |
NCT05942001 -
Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
|
Phase 1 | |
Active, not recruiting |
NCT04117594 -
Whole Body Magnetic Resonance Imaging Study
|
||
Not yet recruiting |
NCT06369246 -
PRORAD-5 PROstate RADiation in 5 Fractions: Phase Ib Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer
|
Phase 2 | |
Completed |
NCT01383863 -
A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer
|
||
Completed |
NCT03651271 -
Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer
|
Phase 2 | |
Active, not recruiting |
NCT05590793 -
Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
|
Phase 3 | |
Recruiting |
NCT06095089 -
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer
|
Phase 1 | |
Active, not recruiting |
NCT02362620 -
PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.
|
||
Active, not recruiting |
NCT02787837 -
PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate.
|
||
Recruiting |
NCT05800665 -
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
|
Phase 1 | |
Recruiting |
NCT03938649 -
SRAM study_Postate Cancer
|
Phase 2 | |
Completed |
NCT00871585 -
Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide
|
N/A | |
Active, not recruiting |
NCT02922218 -
PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.
|
||
Not yet recruiting |
NCT06335914 -
Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer
|
N/A | |
Terminated |
NCT03577028 -
Study of HPN424 in Patients With Advanced Prostate Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT03971110 -
A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
|
Phase 4 |